loadpatents
Patent applications and USPTO patent grants for Magnuson; Steven R..The latest application filed is for "pyrazolopyrimidine jak inhibitor compounds and methods".
Patent | Date |
---|---|
Pyrazolopyrimidine Jak Inhibitor Compounds And Methods App 20200002345 - Gibbons; Paul ;   et al. | 2020-01-02 |
Therapeutic compounds and uses thereof Grant 10,308,614 - Albrecht , et al. | 2019-06-04 |
Therapeutic compounds and uses thereof Grant 10,258,603 - Albrecht , et al. | 2019-04-16 |
Therapeutic compounds and uses thereof Grant 10,206,931 - Romero , et al. Feb | 2019-02-19 |
Therapeutic compounds and uses thereof Grant 10,202,378 - Adler , et al. Feb | 2019-02-12 |
Therapeutic compounds and uses thereof Grant 10,183,009 - Albrecht , et al. Ja | 2019-01-22 |
Therapeutic compounds and uses thereof Grant 10,150,767 - Albrecht , et al. Dec | 2018-12-11 |
Therapeutic Compounds And Uses Thereof App 20180086720 - Albrecht; Brian K. ;   et al. | 2018-03-29 |
Therapeutic Compounds And Uses Thereof App 20180009805 - Adler; Marc ;   et al. | 2018-01-11 |
Aminoquinazoline and pyridopyrimidine derivatives Grant 9,855,269 - Chen , et al. January 2, 2 | 2018-01-02 |
Therapeutic Compounds And Uses Thereof App 20170342067 - Albrecht; Brian K. ;   et al. | 2017-11-30 |
Therapeutic Compounds And Uses Thereof App 20170340604 - Albrecht; Brian K. ;   et al. | 2017-11-30 |
Therapeutic Compounds And Uses Thereof App 20170340605 - Albrecht; Brian K. ;   et al. | 2017-11-30 |
Therapeutic Compounds And Uses Thereof App 20170312292 - Romero; Anthony F. ;   et al. | 2017-11-02 |
Pyrazolopyrimidine Jak Inhibitor Compounds And Methods App 20170283424 - Gibbons; Paul ;   et al. | 2017-10-05 |
Aminoquinazoline And Pyridopyrimidine Derivatives App 20170173026 - Chen; Huifen ;   et al. | 2017-06-22 |
Aminoquinazoline and pyridopyrimidine derivatives Grant 9,592,235 - Chen , et al. March 14, 2 | 2017-03-14 |
Isoquinoline and naphthyridine derivatives Grant 9,586,956 - Chen , et al. March 7, 2 | 2017-03-07 |
Pyrazolo[1,5-A]pyrimidin-7(4H)-onehistone demethylase inhibitors Grant 9,505,767 - Albrecht , et al. November 29, 2 | 2016-11-29 |
Triazolopyridine Jak Inhibitor Compounds And Methods App 20160333011 - Zhu; Bing-Yan ;   et al. | 2016-11-17 |
Aminoquinazoline And Pyridopyrimidine Derivatives App 20160296525 - Chen; Huifen ;   et al. | 2016-10-13 |
Triazolopyridine JAK inhibitor compounds and methods Grant 9,434,732 - Zhu , et al. September 6, 2 | 2016-09-06 |
Pyrazolopyrimidine Jak Inhibitor Compounds And Methods App 20160244456 - BLANEY; Jeffrey ;   et al. | 2016-08-25 |
Aminoquinazoline and pyridopyrimidine derivatives Grant 9,382,241 - Chen , et al. July 5, 2 | 2016-07-05 |
Triazolopyridine Jak Inhibitor Compounds And Methods App 20160024089 - Zhu; Bing-Yan ;   et al. | 2016-01-28 |
Pyrazolopyrimidine Jak Inhibitor Compounds And Methods App 20150152117 - Gibbons; Paul ;   et al. | 2015-06-04 |
Pyrazolopyrimidine JAK inhibitor compounds and methods Grant 8,999,998 - Gibbons , et al. April 7, 2 | 2015-04-07 |
Triazolopyridine Jak Inhibitor Compounds And Methods App 20140378449 - Zhu; Bing-Yan ;   et al. | 2014-12-25 |
Isoquinoline And Naphthyridine Derivatives App 20140343036 - Chen; Huifen ;   et al. | 2014-11-20 |
Triazolopyridine JAK inhibitor compounds and methods Grant 8,889,673 - Zhu , et al. November 18, 2 | 2014-11-18 |
Imidazopyridine Compounds, Compositions And Methods Of Use App 20140206702 - Lai; Yingjie ;   et al. | 2014-07-24 |
Azabenzothiazole Compounds, Compositions And Methods Of Use App 20140171408 - Blench; Toby Jonathan ;   et al. | 2014-06-19 |
Pyrazolopyrimidine Jak Inhibitor Compounds And Methods App 20140107099 - Blaney; Jeffrey ;   et al. | 2014-04-17 |
Azabenzothiazole compounds, compositions and methods of use Grant 8,697,708 - Blench , et al. April 15, 2 | 2014-04-15 |
Triazolopyridine Jak Inhibitor Compounds And Methods App 20140038939 - Zhu; Bing-Yan ;   et al. | 2014-02-06 |
Pyrazolopyrimidine JAK inhibitor compounds and methods Grant 8,637,526 - Blaney , et al. January 28, 2 | 2014-01-28 |
Triazolopyridine JAK inhibitor compounds and methods Grant 8,609,687 - Zhu , et al. December 17, 2 | 2013-12-17 |
Aminoquinazoline And Pyridopyrimidine Derivatives App 20130324516 - Chen; Huifen ;   et al. | 2013-12-05 |
Janus kinase inhibitor compounds and methods Grant 8,486,950 - Goodacre , et al. July 16, 2 | 2013-07-16 |
Imidazopyridine Compounds, Compositions And Methods Of Use App 20130096104 - Lai; Yingjie ;   et al. | 2013-04-18 |
Triazolopyridine Jak Inhibitor Compounds And Methods App 20120264747 - Zhu; Bing-Yan ;   et al. | 2012-10-18 |
Triazolopyridine Jak Inhibitor Compounds And Methods App 20120225855 - Zhu; Bing-Yan ;   et al. | 2012-09-06 |
Azabenzothiazole Compounds, Compositions And Methods Of Use App 20120202788 - Blench; Toby Jonathan ;   et al. | 2012-08-09 |
Pyrazolopyrimidine Jak Inhibitor Compounds And Methods App 20120190665 - Gibbons; Paul ;   et al. | 2012-07-26 |
Pyrazolopyrimidine Jak Inhibitor Compounds And Methods App 20120022043 - Blaney; Jeffrey ;   et al. | 2012-01-26 |
Janus Kinase Inhibitor Compounds And Methods App 20100317643 - GOODACRE; SIMON CHARLES ;   et al. | 2010-12-16 |
Triazolopyridine JAK Inhibitor Compounds and Methods App 20100048557 - ZHU; Bing-Yan ;   et al. | 2010-02-25 |
Triazolopyridine Jak Inhibitor Compounds And Methods App 20100035875 - ZHU; Bing-Yan ;   et al. | 2010-02-11 |
1,8 Naphthyridine derivatives and their use to treat diabetes and related disorders Grant 7,109,196 - Wang , et al. September 19, 2 | 2006-09-19 |
1, 8-Naphthyridine derivatives and their use to treat diabetes and related disorders App 20060189609 - Wang; Yamin ;   et al. | 2006-08-24 |
2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists App 20050215594 - O'Connor, Stephen J. ;   et al. | 2005-09-29 |
2,6-substituted chroman derivatives useful as beta-3 adrenoreceptor agonists Grant 6,919,371 - O'Connor , et al. July 19, 2 | 2005-07-19 |
1,8-Naphthyridine derivatives and their use to treat diabetes and related disorders Grant 6,900,205 - Wang , et al. May 31, 2 | 2005-05-31 |
1,8 Naphthyridine derivatives and their use to treat diabetes and related disorders App 20040209866 - Wang, Yamin ;   et al. | 2004-10-21 |
Substituted indoles, pharmaceutical compounds containing such indoles and their use as PPAR-.gamma. binding agents Grant 6,787,651 - Stolle , et al. September 7, 2 | 2004-09-07 |
2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists App 20040072828 - O'Connor, Stephen J. ;   et al. | 2004-04-15 |
Di-substituted aminomethyl-chroman derivative beta-3 adrenoreceptor agonists Grant 6,699,860 - Ladouceur , et al. March 2, 2 | 2004-03-02 |
1,8-Naphthyridine derivatives and their use to treat diabetes and related disorders App 20040014751 - Wang, Yamin ;   et al. | 2004-01-22 |
2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists Grant 6,660,752 - O'Connor , et al. December 9, 2 | 2003-12-09 |
Substituted indoles, pharmaceutical compounds containing such indoles and their use as PPAR-gamma binding agents App 20030087902 - Stolle, Andreas ;   et al. | 2003-05-08 |
Di-substituted aminomethyl-chroman derivative beta-3 adrenoreceptor agonists App 20030078258 - Ladouceur, Gaetan H. ;   et al. | 2003-04-24 |
2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists App 20030078260 - O'Connor, Stephen J. ;   et al. | 2003-04-24 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.